Cell Growth & Differentiation, Vol 5, Issue 10 1041-1050, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Activation of p34cdc2 coincident with taxol-induced apoptosis

KL Donaldson, GL Goolsby, PA Kiener and AF Wahl
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.

Toxicity elicited by the antitumor compound taxol has been linked to irreversible tubulin polymerization, cell cycle block at mitosis, and cell death from apoptosis. We have used pulsed drug exposure of synchronized populations to identify two points, one in transition from G0 to G1 and the other at G2/M of cell cycle, that are most sensitive to taxol-induced cell killing. By analyzing these lesions separately, we have differentiated events related to mitotic block from those that may contribute to apoptosis. The taxol lesion forms rapidly and stably in transition or mitotic cells, because secondary washes to remove residual drug will decrease cytotoxicity except for cells in these populations. Both G2/M cells and G0/G1 transition cells synchronously initiated apoptotic DNA fragmentation within 20 h of pulsed taxol treatment, indicating that a sustained mitotic block is not requisite to initiate cell death. Apoptosis was inhibited by cyclohexamide and by 2-aminopurine and sodium orthovanadate; thus, cell cycle progression appeared requisite for cell death. Taxol treatment of G0/G1 or G2/M cells clearly leads to a block of mitosis followed by a perturbation of tyrosine phosphoprotein regulation; however, protein tyrosine phosphorylation correlated with mitotic block rather than time after drug exposure. Conversely, p34cdc2 kinase activation does not occur at mitotic block but rather 20 h after drug exposure and coincident with DNA fragmentation. Taken together, these results suggest that mitotic block may not be a sufficient signal for taxol-induced apoptosis and that the taxol lesion initiates apoptosis via a phosphoregulation pathway possibly involving the p34cdc2 kinase.

This article has been cited by other articles:

				S.-W. Wang, S.-L. Pan, Y.-C. Huang, J.-H. Guh, P.-C. Chiang, D.-Y. Huang, S.-C. Kuo, K.-H. Lee, and C.-M. Teng CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo Mol. Cancer Ther., February 1, 2008; 7(2): 350 - 360. [Abstract] [Full Text] [PDF]

				J. M. Mulligan, L. M. Greene, S. Cloonan, M. M. Mc Gee, V. Onnis, G. Campiani, C. Fattorusso, M. Lawler, D. C. Williams, and D. M. Zisterer Identification of Tubulin as the Molecular Target of Proapoptotic Pyrrolo-1,5-benzoxazepines Mol. Pharmacol., July 1, 2006; 70(1): 60 - 70. [Abstract] [Full Text] [PDF]

				T. Takahashi, F. Yamasaki, T. Sudo, H. Itamochi, S. Adachi, M. Tamamori-Adachi, and N. T. Ueno Cyclin A-associated kinase activity is needed for paclitaxel sensitivity Mol. Cancer Ther., July 1, 2005; 4(7): 1039 - 1046. [Abstract] [Full Text] [PDF]

				C. K. Prasad, K. R. Resmi, L. K. Krishnan, and R. Vaishnav Survival of Endothelial Cells in vitro on Paclitaxel-loaded Coronary Stents J Biomater Appl, April 1, 2005; 19(4): 271 - 286. [Abstract] [PDF]

				J. H. Shin, H.-Y. Song, C. G. Choi, S. H. Yuk, J.-S. Kim, Y. M. Kim, C. J. Yoon, T.-H. Kim, J.-Y. Suh, and X. He Tissue Hyperplasia: Influence of a Paclitaxel-eluting Covered Stent--Preliminary Study in a Canine Urethral Model Radiology, February 1, 2005; 234(2): 438 - 444. [Abstract] [Full Text] [PDF]

				J.-G. Chen, C.-P. H. Yang, M. Cammer, and S. Band Horwitz Gene Expression and Mitotic Exit Induced by Microtubule-Stabilizing Drugs Cancer Res., November 15, 2003; 63(22): 7891 - 7899. [Abstract] [Full Text] [PDF]

				Y.-H. Ling, J.-D. Jiang, J. F. Holland, and R. Perez-Soler Arsenic Trioxide Produces Polymerization of Microtubules and Mitotic Arrest before Apoptosis in Human Tumor Cell Lines Mol. Pharmacol., September 1, 2002; 62(3): 529 - 538. [Abstract] [Full Text] [PDF]

				S. C. Coleman, Z. A. Stewart, T. A. Day, J. L. Netterville, B. B. Burkey, and J. A. Pietenpol Analysis of Cell-Cycle Checkpoint Pathways in Head and Neck Cancer Cell Lines: Implications for Therapeutic Strategies Arch Otolaryngol Head Neck Surg, February 1, 2002; 128(2): 167 - 176. [Abstract] [Full Text] [PDF]

				K. Ye, J. Zhou, J. W. Landen, E. M. Bradbury, and H. C. Joshi Sustained Activation of p34cdc2 Is Required for Noscapine-induced Apoptosis J. Biol. Chem., December 7, 2001; 276(50): 46697 - 46700. [Abstract] [Full Text] [PDF]

				N. V. Koshkina, J. C. Waldrep, L. E. Roberts, E. Golunski, S. Melton, and V. Knight Paclitaxel Liposome Aerosol Treatment Induces Inhibition of Pulmonary Metastases in Murine Renal Carcinoma Model Clin. Cancer Res., October 1, 2001; 7(10): 3258 - 3262. [Abstract] [Full Text] [PDF]

				M. A. Shah and G. K. Schwartz Cell Cycle-mediated Drug Resistance: An Emerging Concept in Cancer Therapy Clin. Cancer Res., August 1, 2001; 7(8): 2168 - 2181. [Abstract] [Full Text] [PDF]

				A. Farb, P. F. Heller, S. Shroff, L. Cheng, F. D. Kolodgie, A. J. Carter, D. S. Scott, J. Froehlich, and R. Virmani Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent Circulation, July 24, 2001; 104(4): 473 - 479. [Abstract] [Full Text] [PDF]

				S. Bonatti, S. Pigullo, M. Simili, and A. Abbondandolo Induction of apoptosis and inhibition of signalling pathways by alkylated purines Mutagenesis, July 1, 2000; 15(4): 361 - 366. [Abstract] [Full Text] [PDF]

				S. J. Chmura, M. E. Dolan, A. Cha, H. J. Mauceri, D. W. Kufe, and R. R. Weichselbaum In Vitro and in Vivo Activity of Protein Kinase C Inhibitor Chelerythrine Chloride Induces Tumor Cell Toxicity and Growth Delay in Vivo Clin. Cancer Res., February 1, 2000; 6(2): 737 - 742. [Abstract] [Full Text]

				K. S. Choi, Y. W. Eom, Y. Kang, M. J. Ha, H. Rhee, J.-W. Yoon, and S.-J. Kim Cdc2 and Cdk2 Kinase Activated by Transforming Growth Factor-beta 1 Trigger Apoptosis through the Phosphorylation of Retinoblastoma Protein in FaO Hepatoma Cells J. Biol. Chem., November 5, 1999; 274(45): 31775 - 31783. [Abstract] [Full Text] [PDF]

				B. Verdoodt, I. Decordier, K. Geleyns, M. Cunha, E. Cundari, and M. Kirsch-Volders Induction of polyploidy and apoptosis after exposure to high concentrations of the spindle poison nocodazole Mutagenesis, September 1, 1999; 14(5): 513 - 520. [Abstract] [Full Text] [PDF]

				K. R. Johnson, K. K. Young, and W. Fan Antagonistic Interplay between Antimitotic and G1-S Arresting Agents Observed in Experimental Combination Therapy Clin. Cancer Res., September 1, 1999; 5(9): 2559 - 2565. [Abstract] [Full Text] [PDF]

				B. Kurdoglu, N. Cheong, J. Guan, B. W. Corn, W. J. Curran Jr., and G. Iliakis Apoptosis as a Predictor of Paclitaxel-induced Radiosensitization in Human Tumor Cell Lines Clin. Cancer Res., September 1, 1999; 5(9): 2580 - 2587. [Abstract] [Full Text] [PDF]

				Z. A. Stewart, D. Mays, and J. A. Pietenpol Defective G1-S Cell Cycle Checkpoint Function Sensitizes Cells to Microtubule Inhibitor-induced Apoptosis Cancer Res., August 1, 1999; 59(15): 3831 - 3837. [Abstract] [Full Text] [PDF]

				D. Dhawan, S. Balasubramanian, A. J. Amonkar, and N. Singh Chemopreventive effect of 4'-demethyl epipodophyllotoxin on DMBA/TPA-induced mouse skin carcinogenesis Carcinogenesis, June 1, 1999; 20(6): 997 - 1003. [Abstract] [Full Text] [PDF]

				W. Li, J. Fan, D. Banerjee, and J. R. Bertino Overexpression of p21waf1 Decreases G2-M Arrest and Apoptosis Induced by Paclitaxel in Human Sarcoma Cells Lacking Both p53 and Functional Rb Protein Mol. Pharmacol., June 1, 1999; 55(6): 1088 - 1093. [Abstract] [Full Text]

				S. Gibson, C. Widmann, and G. L. Johnson Differential Involvement of MEK Kinase 1 (MEKK1) in the Induction of Apoptosis in Response to Microtubule-targeted Drugs versus DNA Damaging Agents J. Biol. Chem., April 16, 1999; 274(16): 10916 - 10922. [Abstract] [Full Text] [PDF]

				T.-H. Wang, D. M. Popp, H.-S. Wang, M. Saitoh, J. G. Mural, D. C. Henley, H. Ichijo, and J. Wimalasena Microtubule Dysfunction Induced by Paclitaxel Initiates Apoptosis through Both c-Jun N-terminal Kinase (JNK)-dependent and -Independent Pathways in Ovarian Cancer Cells J. Biol. Chem., March 19, 1999; 274(12): 8208 - 8216. [Abstract] [Full Text] [PDF]

				J. M. Coco Martin, A. Balkenende, T. Verschoor, F. Lallemand, and R. Michalides Cyclin D1 Overexpression Enhances Radiation-induced Apoptosis and Radiosensitivity in a Breast Tumor Cell Line Cancer Res., March 1, 1999; 59(5): 1134 - 1140. [Abstract] [Full Text] [PDF]

				M. J. Hendzel, W. K. Nishioka, Y. Raymond, C. D. Allis, D. P. Bazett-Jones, and J. P. H. Th'ng Chromatin Condensation Is Not Associated with Apoptosis J. Biol. Chem., September 18, 1998; 273(38): 24470 - 24478. [Abstract] [Full Text] [PDF]

				R. K. Srivastava, A. R. Srivastava, S. J. Korsmeyer, M. Nesterova, Y. S. Cho-Chung, and D. L. Longo Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase Mol. Cell. Biol., June 1, 1998; 18(6): 3509 - 3517. [Abstract] [Full Text]

				P. J. Moos and F. A. Fitzpatrick Taxane-mediated gene induction is independent of microtubule stabilization: Induction of transcription regulators and enzymes that modulate inflammation and apoptosis PNAS, March 31, 1998; 95(7): 3896 - 3901. [Abstract] [Full Text] [PDF]

				D. I. Axel, W. Kunert, C. Goggelmann, M. Oberhoff, C. Herdeg, A. Kuttner, D. H. Wild, B. R. Brehm, R. Riessen, G. Koveker, et al. Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery Circulation, July 15, 1997; 96(2): 636 - 645. [Abstract] [Full Text]

				A. A. Matassa, L. Carpenter, T. J. Biden, M. J. Humphries, and M. E. Reyland PKCdelta Is Required for Mitochondrial-dependent Apoptosis in Salivary Epithelial Cells J. Biol. Chem., August 3, 2001; 276(32): 29719 - 29728. [Abstract] [Full Text] [PDF]